Anacor $5.2 billion acquisition by Pfizer
Davis Polk is advising Anacor Pharmaceuticals, Inc. on its approximately $5.2 billion acquisition by Pfizer Inc. The closing of the transaction, which is expected in the third quarter…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Pacific Exploration & Production Corp. $5.3 Billion Restructuring and $634 Million Debtor-in-Possession Financing
Davis Polk is advising the administrative agent under a $1 billion prepetition unsecured revolving credit facility in connection with Pacific Exploration & Production Corp.’s (together…
Davis Polk Advises OneMain on the Sale of Its Interest in SpringCastle
Davis Polk advised the special committee of the board of directors of OneMain Holdings, Inc. in connection with the sale of its 47% interest in SpringCastle, a joint venture formed to…
Davis Polk Advises Metalmark Capital on Its Majority Investment in WorldStrides and Related Financing
Davis Polk advised Metalmark Capital in connection with its majority investment in WorldStrides. Under the terms of the sale and merger agreement, The Carlyle Group and its co-investors…
Davis Polk Advises Fandango on Its Acquisition of Ingresso.com
Davis Polk is advising Fandango in connection with its acquisition of Ingresso.com from B2W Companhia Digital, a Latin American e-commerce company. The financial terms of the transaction…
Davis Polk Advises SS&C on Its Acquisition of Primatics Financial
Davis Polk is advising SS&C Technologies Holdings, Inc. in connection with its approximately $122 million acquisition of Primatics Financial from The Carlyle Group. The acquisition is…